1.10
price down icon14.40%   -0.185
pre-market  시장 영업 전:  1.16   0.06   +5.45%
loading
전일 마감가:
$1.285
열려 있는:
$1.37
하루 거래량:
968.15K
Relative Volume:
0.11
시가총액:
$3.03M
수익:
-
순이익/손실:
$-31.45M
주가수익비율:
-1.7742
EPS:
-0.62
순현금흐름:
$-24.56M
1주 성능:
-31.25%
1개월 성능:
+166.34%
6개월 성능:
-54.92%
1년 성능:
-89.40%
1일 변동 폭
Value
$1.095
$1.37
1주일 범위
Value
$1.095
$1.80
52주 변동 폭
Value
$0.2806
$335.84

Genprex Inc Stock (GNPX) Company Profile

Name
명칭
Genprex Inc
Name
전화
512-537-7997
Name
주소
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Name
직원
25
Name
트위터
@genprex
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
GNPX's Discussions on Twitter

GNPX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
GNPX 1.10 3.03M 0 -31.45M -24.56M -0.62
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Genprex Inc Stock (GNPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-01-26 개시 National Securities Buy
2019-04-29 개시 Noble Capital Markets Outperform

Genprex Inc 주식(GNPX)의 최신 뉴스

pulisher
Nov 20, 2024

Genprex secures exclusive gene therapy license for cancer By Investing.com - Investing.com South Africa

Nov 20, 2024
pulisher
Nov 20, 2024

Genprex secures exclusive gene therapy license for cancer - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer - PR Newswire

Nov 20, 2024
pulisher
Nov 20, 2024

Genprex faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 20, 2024

Genprex faces Nasdaq delisting over equity shortfall - Investing.com

Nov 20, 2024
pulisher
Nov 12, 2024

U.S. Stock market top gainers: Mullen Automotive gains 92.92% while Genprex increases by 54.48% during mid day trading - Business Upturn

Nov 12, 2024
pulisher
Nov 06, 2024

Genprex reports promising preclinical data on cancer therapy - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting - BioSpace

Nov 06, 2024
pulisher
Nov 05, 2024

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Thera - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Genprex regains Nasdaq compliance with bid price rule - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Genprex regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 05, 2024

Genprex reports promising preclinical data on cancer therapy By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Nov 04, 2024

Genprex Announces Sponsored Research Agreement with The Universi - GuruFocus.com

Nov 04, 2024
pulisher
Nov 02, 2024

Short Interest in Genprex, Inc. (NASDAQ:GNPX) Increases By 5.2% - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

Genprex to Participate in 2024 BIO Europe Conference - The Malaysian Reserve

Oct 31, 2024
pulisher
Oct 31, 2024

Investor Excitement Sparks Genprex (GNPX) Stock Rally - Stocks Telegraph

Oct 31, 2024
pulisher
Oct 28, 2024

Genprex reports positive preclinical gene therapy data By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Genprex reports positive preclinical gene therapy data - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma - The Malaysian Reserve

Oct 28, 2024
pulisher
Oct 26, 2024

Genprex (NASDAQ:GNPX) Announces Sponsored Research Agreement with University of Michigan Rogel Cancer Center for Study on TUSC2 Gene Therapy in ALK-Positive Lung Cancer Patients - Defense World

Oct 26, 2024
pulisher
Oct 25, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Genprex explores gene therapy in lung cancer study - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Genprex explores gene therapy in lung cancer study By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Genprex signs two lung cancer research agreements - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive - StreetInsider.com

Oct 24, 2024
pulisher
Oct 24, 2024

3 Penny Stocks to Watch Now, 10/24/24 - TipRanks

Oct 24, 2024
pulisher
Oct 22, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02% - MSN

Oct 22, 2024
pulisher
Oct 22, 2024

2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now - Yahoo Finance

Oct 22, 2024
pulisher
Oct 22, 2024

Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga

Oct 22, 2024
pulisher
Oct 22, 2024

‘Permanent should mean Permanent’: Purbeck calls for commitment to Full Expensing - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

TD Bank becomes liquidity provider for LTX - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

UK economy 'set to accelerate', says IMF - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

IMF's economic view: A brighter outlook for US but still-tepid global growth - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

Scotch whisky business Compass Box in overseas push - Yahoo News

Oct 22, 2024
pulisher
Oct 22, 2024

Siemens secures contract to optimise Unibuss’ electric fleet with Depot360 - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

US dough business Urban Farmer appoints Chris Jaromin as new CEO - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

DHL Supply Chain to close Canal Winchester warehouse, lay off more than 150 workers - Yahoo News

Oct 22, 2024
pulisher
Oct 22, 2024

QC Copper to acquire remaining 50% of Roger Gold-Copper Project - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

CAC introduces cyber cover for energy and utility sectors - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

How small Canadian retailers are thriving on multiple sales channels - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

Zymeworks doses first subject in Phase I trial of ZW171 for various forms of cancer - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

2 Low-Cost Vanguard ETFs for Set-and-Forget Investors - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

Eleven unveils AI-driven software tailored for accounting - Yahoo News

Oct 22, 2024
pulisher
Oct 22, 2024

Excelsior gets final permit for Arizona copper mine operations - Yahoo News

Oct 22, 2024
pulisher
Oct 22, 2024

The Dean Group acquires 280-room Roomer’s Munich hotel - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

JCP urges Cheesecake to spin off three brands for growth - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

Kmart just closed its last full store — but there’s still a location in Kendall - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

These Are the 5 Most Shorted Stocks in the S&P 500 Index. The Bears Are Wrong About 1 of Them. - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

This Big Social Security Change Was Just Announced, and It Will Affect Your 2025 Benefits - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

HSBC splits up bank amid growing tensions between China and the West - Yahoo! Voices

Oct 22, 2024
pulisher
Oct 22, 2024

Regeneron Pharmaceuticals (REGN) Stock Drops Amid Market Volatility - GuruFocus.com

Oct 22, 2024

Genprex Inc (GNPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
자본화:     |  볼륨(24시간):